Petr Vladimirovich Kruglyakov
Director Ejecutivo en PHARMSYNTHEZ .
Perfil
Petr Vladimirovich Kruglyakov is currently the Director General at Pharmsynthez PJSC.
He previously worked as the Director-Research & Development at Artgen Biotech PJSC from 2010 to 2011 and as the Executive Director at SynBio LLC from 2013 to 2014.
Dr. Kruglyakov obtained his undergraduate degree from the State University of St. Petersburg.
Cargos activos de Petr Vladimirovich Kruglyakov
| Empresas | Cargo | Inicio |
|---|---|---|
| PHARMSYNTHEZ | Director Ejecutivo | 01/01/2014 |
Antiguos cargos conocidos de Petr Vladimirovich Kruglyakov.
| Empresas | Cargo | Fin |
|---|---|---|
SynBio LLC
 SynBio LLC Pharmaceuticals: MajorHealth Technology SynBio LLC engages in original research and introduction of conceptually new medicines. The firm’s medicines help treat diseases like liver disease, cardiovascular disease, acute leukemia, growth hormone deficiency and diabetes milletus. Its work is based on scientific developments and conducted in cutting edge laboratories. The company was founded in 2011 and is headquartered in Moscow, Russian Federation. | Director Ejecutivo | 01/01/2013 |
| HUMAN STEM CELLS INSTITUTE | Director Técnico/Científico/I+D | 01/01/2011 |
Formación de Petr Vladimirovich Kruglyakov.
| State University of St. Petersburg | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| PHARMSYNTHEZ | Health Technology |
| HUMAN STEM CELLS INSTITUTE | Health Services |
| Empresas privadas | 1 |
|---|---|
SynBio LLC
SynBio LLC Pharmaceuticals: MajorHealth Technology SynBio LLC engages in original research and introduction of conceptually new medicines. The firm’s medicines help treat diseases like liver disease, cardiovascular disease, acute leukemia, growth hormone deficiency and diabetes milletus. Its work is based on scientific developments and conducted in cutting edge laboratories. The company was founded in 2011 and is headquartered in Moscow, Russian Federation. | Health Technology |
- Bolsa de valores
- Insiders
- Petr Vladimirovich Kruglyakov
